1 Gwanak-ro
Gwanak-gu
Seoul
Korea, Republic of (South Korea)
Cholangiocarcinoma; IDH1 mutation; Ivosidenib; Phase 3 study
FGR2, fusion; rearrangement; pemigatinib; INCB054828; intrahepatic cholangiocarcinoma; cholangiocarcinoma; biliary tract cancer
Influenza, vaccination, immune checkpoint inhibitor, immunogenicity, immune-related adverse event